Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer announces 'positive' bivalent rLP2086 Phase 2 study results
Pfizer announces 'positive' bivalent rLP2086 Phase 2 study results
Pfizer announces 'positive' bivalent rLP2086 Phase 2 study results
Submitted by
admin
on May 9, 2014 - 10:39am
Source:
The Fly on the Wall
News Tags:
Pfizer
bivalent rLP2086
vaccines
meningococcal disease
Headline:
Pfizer announces 'positive' bivalent rLP2086 Phase 2 study results
Do Not Allow Advertisers to Use My Personal information
